These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8736806)

  • 41. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypothalamic neuropeptide Y and its neuroendocrine regulation by leptin.
    Widdowson PS; Wilding JP
    Front Horm Res; 2000; 26():71-86. PubMed ID: 10767942
    [No Abstract]   [Full Text] [Related]  

  • 43. Peptide-amine interactions in the hypothalamic paraventricular nucleus: analysis of galanin and neuropeptide Y in relation to feeding.
    Kyrkouli SE; Stanley BG; Hutchinson R; Seirafi RD; Leibowitz SF
    Brain Res; 1990 Jun; 521(1-2):185-91. PubMed ID: 1698509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Viral mediated neuropeptide Y expression in the rat paraventricular nucleus results in obesity.
    Tiesjema B; la Fleur SE; Luijendijk MC; Brans MA; Lin EJ; During MJ; Adan RA
    Obesity (Silver Spring); 2007 Oct; 15(10):2424-35. PubMed ID: 17925468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise.
    Santti E; Huupponen R; Rouru J; Hänninen V; Pesonen U; Jhanwar-Uniyal M; Koulu M
    Br J Pharmacol; 1994 Dec; 113(4):1231-6. PubMed ID: 7889277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic effects of neuropeptide Y injections into the paraventricular nucleus of the hypothalamus.
    Menéndez JA; McGregor IS; Healey PA; Atrens DM; Leibowitz SF
    Brain Res; 1990 May; 516(1):8-14. PubMed ID: 2364284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opposite regulation of hypothalamic orexin and neuropeptide Y receptors and peptide expressions in obese Zucker rats.
    Beck B; Richy S; Dimitrov T; Stricker-Krongrad A
    Biochem Biophys Res Commun; 2001 Aug; 286(3):518-23. PubMed ID: 11511089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY.
    Mashiko S; Ishihara A; Iwaasa H; Sano H; Oda Z; Ito J; Yumoto M; Okawa M; Suzuki J; Fukuroda T; Jitsuoka M; Morin NR; MacNeil DJ; Van der Ploeg LH; Ihara M; Fukami T; Kanatani A
    Endocrinology; 2003 May; 144(5):1793-801. PubMed ID: 12697685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Central stimulation of oxytocin release in the lactating rat: interaction of neuropeptide Y with alpha-1-adrenergic mechanisms.
    Parker SL; Crowley WR
    Endocrinology; 1993 Feb; 132(2):658-66. PubMed ID: 8381069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropeptide Y in relation to carbohydrate intake, corticosterone and dietary obesity.
    Wang J; Akabayashi A; Dourmashkin J; Yu HJ; Alexander JT; Chae HJ; Leibowitz SF
    Brain Res; 1998 Aug; 802(1-2):75-88. PubMed ID: 9748512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neural site of leptin influence on neuropeptide Y signaling pathways altering feeding and uncoupling protein.
    Kotz CM; Briggs JE; Pomonis JD; Grace MK; Levine AS; Billington CJ
    Am J Physiol; 1998 Aug; 275(2):R478-84. PubMed ID: 9688683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus.
    Horvath TL; Naftolin F; Leranth C; Sahu A; Kalra SP
    Endocrinology; 1996 Jul; 137(7):3069-78. PubMed ID: 8770933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of phenylpropanolamine on Zucker rats selected for fat food preference.
    Svec F; Muehlenhein M; Porter J
    Nutr Neurosci; 2003 Apr; 6(2):93-102. PubMed ID: 12722984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Responsiveness of obese Zucker rats to [D-Trp34]-NPY supports the targeting of Y5 receptor for obesity treatment.
    Beck B; Richy S; Stricker-Krongrad A
    Nutr Neurosci; 2007; 10(5-6):211-4. PubMed ID: 18284029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Injection of neuropeptide Y into the paraventricular nucleus of the hypothalamus inhibits gastric acid secretion in the rat.
    Humphreys GA; Davison JS; Veale WL
    Brain Res; 1988 Jul; 456(2):241-8. PubMed ID: 3061562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Defense of Elevated Body Weight Setpoint in Diet-Induced Obese Rats on Low Energy Diet Is Mediated by Loss of Melanocortin Sensitivity in the Paraventricular Hypothalamic Nucleus.
    Luchtman DW; Chee MJ; Doslikova B; Marks DL; Baracos VE; Colmers WF
    PLoS One; 2015; 10(10):e0139462. PubMed ID: 26444289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A possible role of neuropeptide Y, agouti-related protein and leptin receptor isoforms in hypothalamic programming by perinatal feeding in the rat.
    López M; Seoane LM; Tovar S; García MC; Nogueiras R; Diéguez C; Señarís RM
    Diabetologia; 2005 Jan; 48(1):140-8. PubMed ID: 15616803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular actions of neuropeptide Y in the hypothalamic paraventricular nucleus of conscious Long Evans and Brattleboro rats.
    Harland D; Bennett T; Gardiner SM
    Neurosci Lett; 1988 Feb; 85(2):239-43. PubMed ID: 3374840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Galanin in the hypothalamus raises dopamine and lowers acetylcholine release in the nucleus accumbens: a possible mechanism for hypothalamic initiation of feeding behavior.
    Rada P; Mark GP; Hoebel BG
    Brain Res; 1998 Jul; 798(1-2):1-6. PubMed ID: 9666056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.
    Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J
    Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.